This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
HIV Management Peer-to-Peer
Weight Change During ART: How and Why Does This Happen?
Kathleen McManus, MD, of the University of Virginia, describes the "return to health" phenomenon that can happen when patients initiate ART. "The exact mechanism is still be worked out," she says. (1:07)
Antiretroviral Side Effects: Patient Preferences Evaluated
A discrete choice experiment showed that patients with HIV had different preferences in therapy side effects across short- and long-term studies using different therapy methods. Among the eight side effects identified within the study, weight gain was one of the most undesirable.
Increasing Awareness of PrEP Among MSM in Non-Healthcare Settings
The U.S. Department of Health and Human Services has several lofty goals for the Ending the HIV Epidemic initiative. So, who has been more likely to get the right services and who hasn’t, and what will it take to meet the government’s targets?
Are CVD Risk-Prediction Models Accurate in HIV Patients?
That was the question at the center of a recent meta-analysis, which concluded that certain general and HIV-specific models perform moderately well in predicting cardiovascular disease risk in HIV patients.
Q&A with Sarah L. Braunstein, PhD, MPH: The “Status Neutral” Model
Dr. Braunstein, of the NYC Department of Health and Mental Hygiene, spoke with MedPage Today about the city’s innovative and successful initiatives to increase HIV testing, connect individuals to care or preventive services, and support long-term adherence to treatment and preventive measures.
Statewide Longitudinal Trends in Transmitted HIV-1 Drug Resistance in Rhode Island
Transmitted drug resistance from patients on suboptimal ART increases the risk of treatment failure and disease transmission, but data are limited. These investigators assessed drug resistance mutations among treatment-naïve people in Rhode Island.
Q&A with Michael Relf, PhD: Aging with HIV
Dr. Relf, of Duke University, spoke to us about recent findings related to changes in hospitalization rates and age-related comorbidity burdens of people with HIV.
HIV and Tobacco Use: A Practical Guide for Clinicians
Ask. Advise. Connect. That’s the 3-point plan recommended by a team from Mass General, Harvard Med School, and Albert Einstein for treating patients with HIV who use tobacco.
The Effect of Obesity on Women Living with HIV
According to the results of a new study, it’s clinically important to routinely monitor the weight and body mass index (BMI) of women living with HIV, to help identify those with elevated BMI who may benefit from intervention.
Q&A: Noelle Le Tourneau, MPH, on HIV Treatment Efficacy
Washington University researcher discusses the real-world impacts of less frequent clinical appointments and prescription refills on ART.
HIV-Related Stigma and Fatalism in a Vulnerable Population
Individuals with HIV infection often report social stigma. However, a new study conducted following a recent HIV outbreak reveals a lessening of that stigma, but an apparent increase in fatalism.
Integrating HIV Services With Other Health Services: A Win
Integrating HIV services with other healthcare services was shown to lead to major benefits for patients, such as knowledge of HIV status and obtaining antiretroviral therapy (ART).
Organ Transplants: Safe for HIV-Positive Patients?
Thanks to federal policy and an increasing pool of research, things are looking up for HIV-positive patients in need of a new kidney or liver. As evidence of this, a U.S.-based team recently reported good outcomes among a pool of about 200 recipients.
HIV: The Effects of Prolonged Suppression
These investigators assessed trends in CD4/CD8 by age group over time and the possible links between CD4/CD8 and select comorbid outcomes.
Early HIV Intervention: Assessing Its Effectiveness
How valuable is universal early treatment of HIV versus usual HIV care? A new study looks at 5-year mortality rates for patients in those 2 subsets versus 5-year survival in the general population.
HIV: What New York City Can Teach Us
Trends over a 9-year period in the Big Apple are almost certain to be replicated in many other areas of the world, says an expert who studies people living with HIV.